Dr. Michele S. Kalt, MD

Dr. Kalt practices at Lakeside Medical Organization, a Medical Group Inc. in Burbank, California.

Dr. Kalt's NPI, 1518026186, was assigned on December 8, 2006. Dr. Kalt graduated from Tel Aviv University Sackler in 1991. Dr. Kalt holds California license A51509.

Dr. Kalt's primary practice is Lakeside Medical Organization, a Medical Group Inc., at 191 S Buena Vista St, Burbank, CA 91505 in Los Angeles County. The practice phone is (818) 637-2000.

Dr. Kalt's primary practice is Lakeside Medical Organization, a Medical Group Inc. in Burbank, California. The medical group on file is Lakeside Community Healthcare. Dmand AI also links Dr. Kalt to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalt practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kalt's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kalt is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Kalt's licenses on file in 2 states: California and New York.

Dmand AI lists atrial fibrillation and flutter, chronic hypertension, chronic skin ulcer, coronary artery disease, heart failure, heart valve disorders, high cholesterol and intermittent racing heartbeat (PSVT) among the conditions Dr. Kalt treats.

CMS data shows 326 Medicare services from Dr. Kalt across 9 procedure codes in 2024, for 94 Medicare patients. Medicare paid $21,082 for them. Every service was in an office.

CMS counts 94 Medicare patients who saw Dr. Kalt in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kalt's median patient age at 72, with 49% women.

In 2024, Dr. Kalt wrote 5,217 Medicare Part D claims for 738 patients. 80% of them were for generic drugs. CMS names the drug for 5,012 of them, across 56 drugs with 11 or more claims each, at $1,173,091 in total drug cost. In 2023, CMS named 4,514 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Kalt for performance year 2024, reported as part of a group. Dr. Kalt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kalt as offering telehealth.

CMS Open Payments shows 839 general payments to Dr. Kalt from 44 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 40% of the total. Novartis Pharmaceuticals Corporation paid the most, $42,845. It also lists 1 research payment totaling $550 in 2017.

Dmand AI lists 3 awards for Dr. Kalt. Dr. Kalt serves on Board of Directors American College of Cardiology.

Dr. Kalt graduated from Tel Aviv University Sackler in 1991. Dr. Kalt is a member of ACC.

Dr. Kalt is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.